Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Reaches $2.69 Billion In 2026: Forecast And Growth Opportunities
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Size, Value And Growth Trajectory Through 2030
The quantitative polymerase chain reaction (qpcr) instruments market size has experienced rapid expansion over recent years. Projections indicate it will grow from $1.66 billion in 2025 to $1.83 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. This market’s historical growth can be linked to factors including a rising demand for genetic research, an increasing prevalence of infectious diseases, advancements in molecular diagnostics, the expansion of biotech and pharma research, and the availability of a skilled laboratory workforce.
The quantitative polymerase chain reaction (qpcr) instruments market is forecast to experience significant expansion in the upcoming years. It is projected to reach $2.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. This expected growth can be attributed to several factors, including the increasing uptake of point-of-care diagnostics, the expansion of molecular testing into emerging markets, the integration of AI and cloud-based analytics, a growing demand for rapid pathogen detection, and increased government funding for genomics research. Noteworthy trends during this period are expected to encompass the widespread adoption of high-throughput testing, the incorporation of automation within qPCR workflows, the miniaturization of qPCR instruments, a rising demand for multiplexing capabilities, and the development of point-of-care qPCR solutions.
Get A Free Sample Report With In-Depth Market Insights:
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Growth Backed By Core Demand Fundamentals
The rising occurrence of infectious diseases is anticipated to boost the expansion of the quantitative polymerase chain reaction (qPCR) instruments market moving ahead. These diseases are conditions stemming from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between people either directly or indirectly. The uptick in infectious diseases is attributable to heightened global travel, enabling swift dissemination of pathogens across different regions. Quantitative polymerase chain reaction (qPCR) instruments play a crucial role in combating infectious diseases by facilitating quick, sensitive, and accurate pathogen detection, thereby supporting prompt diagnosis and efficient disease control. For example, data from February 2024, provided by GOV.UK, a UK-based government department, indicated that tuberculosis (TB) cases in England rose from 4,380 in 2022 to 4,850 in 2023. Consequently, the growing prevalence of infectious diseases is fueling the development of the quantitative polymerase chain reaction (qPCR) instruments market.
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Segmentation And Category Overview
The quantitative polymerase chain reaction (qpcr) instruments market covered in this report is segmented –
1) By Product Type: Quantitative Polymerase Chain Reaction Systems, Reagents And Consumables, Software
2) By Instrument: 7500, Viia 7 Dx, Cobas 4800, Cfx96, Smartcycler, Genexpert, Rotor-Gene Q, Rotor-Gene Q 5plex Hrm System, Biofire Filmarray Systems, Other Instruments
3) By Application: Gene Expression, Genotyping, Pathogen Detection, Diagnostics, Other Applications
4) By End-Users: Diagnostic Laboratories, Hospitals And Clinics, Pharma And Biotech Companies, Other End-Users
Subsegments:
1) By Quantitative Polymerase Chain Reaction (qPCR) Systems: Real-Time Polymerase Chain Reaction Systems, Portable Or Compact qPCR Devices, Digital Polymerase Chain Reaction Systems
2) By Reagents And Consumables: Master Mixes, Buffers And Enzymes, Primers
3) By Software: Data Analysis Software, Cloud-Based Analytics Platforms, Instrument Control Software
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Growth Trends Reshaping The Competitive Landscape
Leading companies within the Quantitative Polymerase Chain Reaction (qPCR) Instruments market are concentrating on developing innovative solutions, including next-generation real-time qPCR systems that combine clinical-grade workflows with research flexibility. This effort aims to address the increasing demand for quicker, higher-throughput molecular diagnostics, enhanced assay sensitivity crucial for personalized medicine and oncology, and improved preparedness for infectious disease testing. A next-generation qPCR system is a real-time PCR instrument that upholds the core principle of qPCR—simultaneous amplification and fluorescent detection of nucleic acids—while incorporating additional features such as improved thermal uniformity, advanced signal-processing algorithms, ergonomic user interfaces, and regulatory-compliant IVD workflows. For example, in November 2023, Roche Holding AG, a Switzerland-based diagnostics and biotechnology company, launched the LightCycler PRO System, an innovative next-generation qPCR platform. Building on Roche’s LightCycler heritage, the LightCycler PRO System is designed for both research and IVD applications. It incorporates a new vapor chamber to enhance temperature uniformity across the block, boasts updated software and a user interface with refined algorithms for signal analysis, and offers the flexibility to run user-developed assays alongside a wide array of validated LightMix research and CE-IVD assays.
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Leading Players And Competitive Positioning
Major companies operating in the quantitative polymerase chain reaction (qpcr) instruments market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc, Bio Rad Laboratories Inc, QIAGEN N V, Eppendorf SE, Cepheid Inc, Takara Bio Inc, bioMerieux SA, Analytik Jena GmbH, Standard BioTools Inc, Hangzhou Bioer Technology Co Ltd, BioTeke Corporation, GeneReach Biotechnology Corp, Anitoa Systems LLC, Blue Ray Biotech Corp, Chai Biotechnologies, Bio Molecular Systems Pty Ltd, Azure Biosystems Inc
View The Full Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Report:
Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the quantitative polymerase chain reaction (qpcr) instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
